Relevant bibliographies by topics / Ribavirine

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Ribavirine'

Author: Grafiati
Published: 4 June 2021
Last updated: 26 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Ribavirine.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Ribavirine"

1

Ciancio, Alessia. "Sofosbuvir: an all-around drug in hepatitis C treatment new era – The first phase." Reviews in Health Care 6, no. 2 (2015): 41–52. http://dx.doi.org/10.7175/rhc.v6i2.1164.

Full text
Abstract:
Chronic hepatitis C virus (HCV) infection is a slowly progressive disease affecting more than 185 million people worldwide. For many years, the combination of pegylated interferon (Peg-IFN) plus ribavirin (RBV) has been the backbone of treatment for patients infected with HCV. More than two years ago, the first generation direct-acting antiviral agents (DAAs) – the protease inhibitors boceprevir and telaprevir – were approved for treatment of genotype 1 patients, doubling the cure rate. The new DAAs that have been developed, are effective for multiple genotypes, improve rates of sustained vira
APA, Harvard, Vancouver, ISO, and other styles
2

Hubert, P. "Ribavirine et ventilation mécanique." Archives de Pédiatrie 3, no. 2 (1996): 186. http://dx.doi.org/10.1016/0929-693x(96)85076-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Prasad, Bobby S., Saranya T. S, Akhila P, Architha Pradeep, Serah Kuriakose, and Vishnupriya V. S. "MOLECULAR DOCKING OF PHYTOCONSTITUENTS TO EVALUATE ANTIVIRAL EFFECTIVENESS AGAINST NIPAH VIRUS ATTACHMENT GLYCOPROTEIN." INDIAN DRUGS 62, no. 05 (2025): 24–32. https://doi.org/10.53879/id.62.05.15297.

Full text
Abstract:
Nipah virus is a biosafety grade 4 microbe with a high death rate, making it a top research priority. Despite the use of synthetic compounds like ribavirine, remdesivir and favipiravir, there is a growing interest in using natural molecules as antiviral agents. Molecular docking studies were conducted to evaluate the antiviral capabilities of isolated compounds from plant species Alstonia scholaris, Picrorhiza kurroa, Swertia chirata and Caesalpinia crista against the Nipah virus attachment glycoprotein. 171 compounds were selected and subjected to screening processes such as Lipinski rule of
APA, Harvard, Vancouver, ISO, and other styles
4

Zivkovic, Milovan, Zoran Todorovic, Predrag Canovic, and Zeljko Mijanovic. "Application of ribavirin in patients having hemorrhagic fever with renal syndrome." Medical review 62, no. 1-2 (2009): 63–67. http://dx.doi.org/10.2298/mpns0902063z.

Full text
Abstract:
Introduction. Hemorrhagic fever with renal syndrome (HFRS) is an acute infective disease of a zoonose type characterized by an abrupt beginning, prominent hemorrhagic syndrome as well as symptoms and signs of acute renal insufficiency. The clinical picture of this disease, which is leading in terms of its natural principal seat in the region of Northern-east Montenegro, ranges from non-apparent to very severe forms and mortality it causes is about 10%.Up to date, no efficient etio-trophic means has been discovered. Several studies suggest that an early use of anti virus medicament Ribavirine l
APA, Harvard, Vancouver, ISO, and other styles
5

M., J. M. "La ribavirine, traitement efficace de l’hépatite E." Revue Francophone des Laboratoires 2014, no. 465 (2014): 21. http://dx.doi.org/10.1016/s1773-035x(14)72619-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sizun, J. "Virus respiratoire syncytial, immunoglobulines spécifiques et ribavirine." Archives de Pédiatrie 4, no. 6 (1997): 554. http://dx.doi.org/10.1016/s0929-693x(97)87579-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ventura, F., JJ Cheseaux, J. Cotting, and JP Guignard. "Infections à virus respiratoire syncytial et ribavirine." Archives de Pédiatrie 5, no. 7 (1998): 809. http://dx.doi.org/10.1016/s0929-693x(98)80072-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Saadoun, D., D. Sene, B. Terrier, et al. "Rituximab et Peg-IFN A/ribavirine comparé au Peg-IFN A/ribavirine dans les vascularites cryoglobulinémiques associées au VHC." La Revue de Médecine Interne 30 (December 2009): S351—S352. http://dx.doi.org/10.1016/j.revmed.2009.10.078.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Karaaslan, H., V. Loustaud-Ratti, P. Soria, et al. "Traitement des glomérulonéphrites membranoprolifératives liées au virus C par la bithérapie interféron alpha-ribavirine : maintenir la ribavirine même à doses réduites !" La Revue de Médecine Interne 22 (June 2001): 166. http://dx.doi.org/10.1016/s0248-8663(01)83623-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

CENGİZ, A. Tevfik, Lügen CENGİZ, Mehmet KIYAN, Muzaffer GÖZ, G. İştar DOLAPÇI, and Meltem TIBET. "Prevention and Treatment of AIDS-IV." European Journal of Therapeutics 3, no. 1 (1992): 101–13. http://dx.doi.org/10.58600/eurjther.19920301-1267.

Full text
Abstract:
In this article principles of prevention and treatınent was explained for AIDS which has been an important and current health problem. At the same time, the other side of this subject, the importance of AIDS both for mother and infant is emphasized the behavior male and female patients with AIDS was dwelled on and activity of antiviral agents like AZT,ddc,ddı,suramine, interferon and ribavirine, was reviewed.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Ribavirine"

1

Hézode, Christophe. "Physiopathologie du traitement de l'hépatite chronique C par les interférons, la ribavirine et les inhibiteurs spécifiques." Thesis, Paris Est, 2011. http://www.theses.fr/2011PEST0087.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bani-Sadr, Firouzé. "Particularités de l'infection VHC et de la thérapeutique anti-VHC chez les patients co-infectés VIH/VHC." Paris 6, 2007. https://tel.archives-ouvertes.fr/tel-00809569.

Full text
Abstract:
En 1998, le traitement de la co-infection VHC rarement discuté avant l’ère des HAART, compte tenu d’une réponse médiocre à la monothérapie par IFN et d’un pronostic de vie lié au VIH estimé en moyenne à 10 ans, fût reconsidéré. C’est ainsi que débuta en 2000, l’essai RIBAVIC HC02, essai randomisé et multicentrique comparant l’association de la ribavirine 800 mg/j à l’Interféron 3 MUI x3/semaine ou au PEG--2b Interféron 1,5 µg/kg/semaine pendant 48 semaines. Une cohorte des patients inclus dans l’essai RIBAVIC (cohorte RIBAVIC EP10) débuta en 2001 pour évaluer le devenir à long terme de ces p
APA, Harvard, Vancouver, ISO, and other styles
3

Cosson, Fanny. "Synthèse d'analogues carbonés de la Ribavirine pour leurs activités antivirales." Phd thesis, Université de Cergy Pontoise, 2014. http://tel.archives-ouvertes.fr/tel-01024035.

Full text
Abstract:
La Ribavirine est un analogue nucléosidique de la guanosine constitué d'un ribose et d'un noyau triazole. Cet antiviral, synthétisé en 1970, possède une activité contre différents virus comme le virus respiratoire syncytial chez les enfants en détresse respiratoire, les virus des hépatites B et E, ainsi que contre certains cancers et leucémies. Elle est surtout connue pour son utilisation dans le traitement de l'hépatite C, en combinaison avec l'Interféron. Cependant, l'efficacité de cette thérapie est limitée à certains génotypes du virus et les effets secondaires résultants sont nombreux. C'
APA, Harvard, Vancouver, ISO, and other styles
4

Cosson, Fanny. "Synthèse d’analogues carbonés de la Ribavirine pour leurs activités antivirales." Thesis, Cergy-Pontoise, 2014. http://www.theses.fr/2014CERG0687/document.

Full text
Abstract:
La Ribavirine est un analogue nucléosidique de la guanosine constitué d'un ribose et d'un noyau triazole. Cet antiviral, synthétisé en 1970, possède une activité contre différents virus comme le virus respiratoire syncytial chez les enfants en détresse respiratoire, les virus des hépatites B et E, ainsi que contre certains cancers et leucémies. Elle est surtout connue pour son utilisation dans le traitement de l'hépatite C, en combinaison avec l'Interféron. Cependant, l'efficacité de cette thérapie est limitée à certains génotypes du virus et les effets secondaires résultants sont nombreux. C'
APA, Harvard, Vancouver, ISO, and other styles
5

Ayari, Mohamed. "Développement de Polymères à Empreintes Moléculaires pour la Libération Controlée de la Ribavirine et de l'Adénosine -5'-monosphosphate." Thesis, Orléans, 2018. http://www.theses.fr/2018ORLE2047/document.

Full text
Abstract:
Empreintes moléculaires pour la libération contrôlée des analogues de nucléosides : la ribavirine pour le traitement du virus Influenza A par voie pulmonaire et l’adénosine-5’-monophosphate.Nous nous sommes concentrés dans un premier lieu au développement de différentes formulations de MIPs enbulk sous forme hydrogels afin de mettre en place des systèmes de libération contrôlée de la ribavirine sous différents stimuli. Ensuite, nous nous sommes basés sur l’approche de « Dummy-template » en utilisant la 2’,3’,5’-tri-O-acétylribavirine afin de diminuer la polarité de la ribavirine et ainsi accéd
APA, Harvard, Vancouver, ISO, and other styles
6

Grancher, Nicolas. "Vectorisation de la ribavirine par les cyclodextrines : caractérisation physico-chimique des complexes et activité in vitro et in vivo sur le virus de la rougeole." Nancy 1, 2005. http://www.theses.fr/2005NAN11301.

Full text
Abstract:
En dépit de la vaccination, la mortalité due au measles virus (MV) reste importante puisqu'elle est estimée à environ 1 million de morts par an, surtout dans les pays en voie de développement. Les complications graves, telle l'encéphalite aiguë, justifient une thérapeutique efficace. Le MV est sensible à la ribavirine (RBV), mais l'utilisation de cette molécule est limitée par sa toxicité. Pour y remédier, nous avons étudié des vecteurs capables de transporter les molécules antivirales: les cyclodextrines (CDs). Ce sont des oligosaccharides cycliques possédant une cavité hydrophobe. Les CDs so
APA, Harvard, Vancouver, ISO, and other styles
7

Jeulin, Hélène. "Impact virologique et pharmacologique de la complexation de la ribavirine aux cyclodextrines sur un modèle animal d'encéphalite rougeoleuse." Thesis, Nancy 1, 2008. http://www.theses.fr/2008NAN10117/document.

Full text
Abstract:
La ribavirine est un agent antiviral à large spectre efficace in vitro contre de nombreux virus à ARN dont certains sont responsables d'encéphalites. In vivo la mauvaise diffusion de cet analogue nucléosidique au niveau de la barrière hémato-encéphalique, limite son efficacité dans le traitement des encéphalites virales. Des études antérieures ont montré la capacité des cyclodextrines natives à former des complexes d’inclusion avec la ribavirine et l’amélioration de l’activité antivirale de la ribavirine in vitro lorsque celle-ci est complexée à l’alpha- ou la bêta-cyclodextrine. Le bénéfice d
APA, Harvard, Vancouver, ISO, and other styles
8

Locher, Sandrine. "Traitement de l'hépatite C après greffe hépatique par l'association ribavirine-interféron alpha /." Genève : [s.n.], 2003. http://www.unige.ch/cyberdocuments/theses2003/LocherS/these.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Chen, Yuxing. "Structure et fonction de la nucléoside diphosphate kinase : rôle dans l'activation des analogues de nucléotides à activité antivirale." Paris 11, 2003. http://www.theses.fr/2003PA112130.

Full text
Abstract:
La nucléoside diphosphate kinase (NDP kinase) catalyse la phosphorylation réversible du NDP aux dépens du nucléoside triphosphate (NTP) par l'intermédiaire d'une phosphohistidine selon un mécanisme de ping-pong. La NDP kinase est impliquée dans la lutte contre le SIDA par son rôle dans l'activation des NRTI (nucleoside analog reverse transcriptase inhibitors), qui sont des médicaments qui ciblent la transcriptase inverse du VIH. Le groupe le 3'-OH du sucre des NRTI utilisées actuellement est absent ou substitué pour la terminaison de la polymérisation. Malheureusement ce groupe est important p
APA, Harvard, Vancouver, ISO, and other styles
10

Jeulin, Hélène Kedzierewicz Francine. "Impact virologique et pharmacologique de la complexation de la ribavirine aux cyclodextrines sur un modèle animal d'encéphalite rougeoleuse." S. l. : Nancy 1, 2008. http://www.scd.uhp-nancy.fr/docnum/SCD_T_2008_0117_JEULIN.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Ribavirine"

1

Thomas, Stapleton, and Royal Society of Medicine (Great Britain), eds. Studies with a broad spectrum antiviral agent. Royal Society of Medicine, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

National Institute for Clinical Excellence., ed. Guidance on the use of Ribavirin and Interferon Alpha for hepatitis C. NICE, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Weisensee, Ursula. Wirkung von Ribavirin auf die Hepatitis-Delta-Virus-Replikation beim Woodchuck. [s.n.], 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Husereau, Donald Robert. Interferon-based therapies for chronic hepatitis C virus infection: An assessment of clinical outcomes. Canadian Coordinating Office for Health Technology Assessment, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Oluleye, Kunmi. The cure of chronic Hepatitis B: One man's cure, one family's experience. IROK Solutions, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bruce, Brady, and Canadian Agency for Drugs and Technologies in Health., eds. Pegylated interferon combined with ribavirin for chronic hepatitis c virus infection: An economic evaluation. Canadian Agency for Drugs and Technologies in Health, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Shepherd, J. Combination therapy (interferon alfa and ribavirin) in the treatment of chronic hepattitis C: A rapid and systematic review. Core Research on behalf of the NCCHTA, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. FDA regulation of ribavirin: Hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, first session, May 28, 1987. U.S. G.P.O., 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Karl, Nicholson, ICN Pharmaceuticals inc, and Royal Society of Medicine (Great Britain), eds. HIV and other highly pathogenic viruses. Royal Society of Medicine Services, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

J, Shepherd, and National Co-ordinating Centre for HTA (Great Britain), eds. Pegylated interferon [alpha]-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: A systematic review and economic evaluation. Gray Publishing on behalf of NCCHTA, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Ribavirine"

1

Kemp, William, and Stuart K. Roberts. "Treatment with Interferon and Ribavirin." In Chronic Hepatitis C Virus. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1192-5_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hong, Zhi, and Craig E. Cameron. "Pleiotropic mechanisms of ribavirin antiviral activities." In Progress in Drug Research. Birkhäuser Basel, 2002. http://dx.doi.org/10.1007/978-3-0348-8171-5_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Marcellin, Patrick, Nathalie Boyer, and Tarik Asselah. "Peginterferon, Ribavirin and Anti-viral Triple Therapy." In Chronic Hepatitis C Virus. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1192-5_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gane, Edward J. "Treating Chronic HCV Without Interferon and/or Ribavirin." In Chronic Hepatitis C Virus. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1192-5_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lau, Johnson Y. N. "Hepatitis C: Development of a Ribavirin Liver-Targeting Prodrug." In Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma. Springer Japan, 2004. http://dx.doi.org/10.1007/978-4-431-53977-3_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Smee, Donald F. "Antiviral Activity of the Nucleotide Analogue Ribavirin 5′-Sulfamate." In ACS Symposium Series. American Chemical Society, 1989. http://dx.doi.org/10.1021/bk-1989-0401.ch009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Shiffman, Mitchell L. "When a Patient Receiving Peginterferon and Ribavirin Therapy Develops Anemia Should I Prescribe Epoetin Alfa or Reduce the Dose of the Ribavirin?" In Curbside Consultation of the Liver. CRC Press, 2024. http://dx.doi.org/10.1201/9781003523758-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Poordad, Fred, and Grace M. Chee. "Pharmacology and Mechanisms of Action of Antiviral Drugs: Ribavirin Analogs." In Advanced Therapy for Hepatitis C. Wiley-Blackwell, 2011. http://dx.doi.org/10.1002/9781444346343.ch5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Gölz, J. "IFN/Ribavirin-Therapie bei HIV/HCV-koinfizierten Drogenabhängigen unter Methadonsubstitution." In HIV-Infekt. Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-642-59683-4_104.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kedrowski, Brant L., and William F. Wacholtz. "Thematic Use of Ribavirin To Illustrate NMR Principles and Techniques." In ACS Symposium Series. American Chemical Society, 2016. http://dx.doi.org/10.1021/bk-2016-1225.ch002.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Ribavirine"

1

Smirnova, O. S., and I. D. Konstantinova. "BIOTECHNOLOGICAL SYNTHESIS THE ANTIVIRAL DRUG RIBAVIRIN ANALOGUES MODIFIED ON THE AMIDE GROUP." In XI МЕЖДУНАРОДНАЯ КОНФЕРЕНЦИЯ МОЛОДЫХ УЧЕНЫХ: БИОИНФОРМАТИКОВ, БИОТЕХНОЛОГОВ, БИОФИЗИКОВ, ВИРУСОЛОГОВ, МОЛЕКУЛЯРНЫХ БИОЛОГОВ И СПЕЦИАЛИСТОВ ФУНДАМЕНТАЛЬНОЙ МЕДИЦИНЫ. IPC NSU, 2024. https://doi.org/10.25205/978-5-4437-1691-6-47.

Full text
Abstract:
Ribavirin (1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide) is a well-known antiviral nucleoside. It has attracted interest for more than 40 years due to its unique spectrum of activity and still unclear mechanism of action. However, ribavirin has a high systemic toxicity and teratogenicity. Therefore, the search for new analogs of ribavirin with lower toxicity and high antiviral activity is still relevant.
APA, Harvard, Vancouver, ISO, and other styles
2

Cosgriff, T. M., P. G. Canonico, L. Hodgson, et al. "RIBAVIRIN: STUDIES OF THE EFFECTS OF THE ANTIVIRAL DRUG ON PLATELET FUNCTION." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644545.

Full text
Abstract:
Ribavirin is a broad-spectrum antiviral drug which is presently undergoing testing in patients with AIDS-related complex. It has also been shown to have activity against respiratory syncytial virus, Sicilian sandfly fever virus, influenza A and B viruses, as well as several hemorrhagic fever viruses. It has proved effective in clinical trials in Lassa fever and shows promise as therapy for hemorrhagic fever with renal syndrome. Because platelet dysfunction may contribute significantly to hemostatic impairment in viral hemorrhagic fever, the effects of ribavirin on platelet function were measur
APA, Harvard, Vancouver, ISO, and other styles
3

Xing, Chen-guang, Ning Chen, Xi-Xian Xie, Xi-Jing Zhao, and Qing-yang Xu. "Construction of Ribavirin Engineering Bacteria." In 2009 International Conference on Environmental Science and Information Application Technology, ESIAT. IEEE, 2009. http://dx.doi.org/10.1109/esiat.2009.50.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Smirnova, O. S., and I. D. Konstantinova. "CHEMO-ENZYMATIC SYNTHESIS OF NEW RIBAVIRIN ANALOGS." In OpenBio-2023. ИПЦ НГУ, 2023. http://dx.doi.org/10.25205/978-5-4437-1526-1-51.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Miranda, Leandro Soter de Mariz e., Rodrigo Octávio Mendonça Alves de Souza, Jacques Uziel, and Nadège Lubin-Germain. "Studies Towards new Ribavirin Nucleoside Analogs." In 14th Brazilian Meeting on Organic Synthesis. Editora Edgard Blücher, 2013. http://dx.doi.org/10.5151/chempro-14bmos-r0137-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kienskaya, K. I., M. F. Bobrov, A. M. Kusmaev, et al. "Physicochemical characterization of ribavirin with spectroscopy and molecular modeling." In PROCEEDINGS OF INTERNATIONAL CONFERENCE ON RECENT TRENDS IN MECHANICAL AND MATERIALS ENGINEERING: ICRTMME 2019. AIP Publishing, 2020. http://dx.doi.org/10.1063/5.0018459.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Casper, M., M. Reichert, F. Grünhage, and F. Lammert. "Ribavirin-Dauertherapie als Therapieoption bei chronischer Hepatitis E Virus-Infektion." In 36. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber. Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0039-3402280.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Stępiński, Janusz, Remigiusz Worch, Joanna Zuberek, et al. "Synthesis and preliminary characterization of mRNA 5' cap analogues containing ribavirin." In XIIIth Symposium on Chemistry of Nucleic Acid Components. Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 2005. http://dx.doi.org/10.1135/css200507479.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Mourin, G., L. Couderc, J. Vernant, et al. "Ribavirin for Respiratory Syncytial Virus Bronchiolitis in Hematopoietic Stem Cell Transplant Patients." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a5958.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Souza, Isadora Bontorin de, Bruna Arese Camara Silva Neto, Ingrid Oliveira Bosenbecker Bauer, Marina Mayumi Laranjeira Caldas Kamei, and Gerson Fernandes Mendes Pereira. "Avanços na terapêutica da COVID-19 pelo uso de antirretrovirais utilizados no tratamento de vírus da imunodeficiência humana: uma revisão de literatura." In XIII Congresso da Sociedade Brasileira de DST - IX Congresso Brasileiro de AIDS - IV Congresso Latino Americano de IST/HIV/AIDS. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/dst-2177-8264-202133p299.

Full text
Abstract:
Introdução: A literatura demonstra que pessoas vivendo com vírus da imunodeficiência humana coinfectadas pelo SARS-CoV-2 têm uma possibilidade de aproximadamente 66% de desenvolver quadros leves da COVID-19. Uma das hipóteses para esse fato é o efeito protetor da terapia antirretroviral nos pacientes coinfectados. Objetivo: Avaliar a eficácia dos tratamentos antirretrovirais no tratamento da COVID-19. Métodos: Foi realizada uma revisão sistemática de literatura com busca no PubMed utilizando a associação dos descritores “COVID-19” AND “HIV” AND “antiretroviral terapy”. Encontraram-se 264 artig
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Ribavirine"

1

Monath, Thomas P. Ribavirin, Interferon, and Antibody Approaches to Prophylaxis and Therapy for Viral Hemorrhagic Fevers. Defense Technical Information Center, 1990. http://dx.doi.org/10.21236/ada233097.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

ตั้งกิจวานิชย์, พิสิฐ, อัญชลี อวิหิงสานนท์, วรพจน์ ทรัพย์ศิริสวัสดิ์ та ін. การศึกษาธรรมชาติการดำเนินโรคของการติดเชื้อไวรัสตับอักเสบซี ความสำคัญทางคลินิคปัจจัยที่เกี่ยวข้องในการรักษาการตอบสนองต่อการรักษา และผลข้างเคียงในผู้ติดเชื้อเอชไอวีที่มีการติดเชื้อไวรัสตับอักเสบซี. จุฬาลงกรณ์มหาวิทยาลัย, 2015. https://doi.org/10.58837/chula.res.2015.24.

Full text
Abstract:
การศึกษานี้เป็นแบบไปข้างหน้าในผู้ป่วยที่ติดเชื้อเอชไอวีร่วมกับการติดเชื้อไวรัสตับอักเสบซีในพื้นที่กรุงเทพมหานคร ประเทศไทย โดยมีการตรวจสายพันธุ์ของไวรัสตับอักเสบซี ปริมาณไวรัสตับอักเสบซีในเลือด ยีน IL-288 และการเกิดพังผืดในตับด้วยเครื่องไฟโบรสแกน และได้แบ่งระยะของพังผืดในตับได้ดังนี้ ระยะแรก (Metavir F0-F1) เป็นระยะที่มีค่า stiffness น้อยกว่าหรือเท่ากับ 7.1 kPa ระยะที่ 2 หรือระยะปานกลาง (F2) เป็นระยะที่มีค่า stiffness ระหว่าง 7.2-9.4 kPa ระยะที่ 3 หรือระยะรุนแรง (F3) เป็นระยะที่มีค่า stiffness ระหว่าง 9.5-14 kPa และระยะสุดท้าย (F4) หรือ โรคตับแข็งที่มีค่า stiffness มากกว่า 14 kPa การตรวจประเมิน
APA, Harvard, Vancouver, ISO, and other styles
3

Tang, Jiqin, Gong Zhang, Jinxiao Xing, Ying Yu, and Tao Han. Network Meta-analysis of Heat-clearing and Detoxifying Oral Liquid of Chinese Medicines in Treatment of Children’s Hand-foot-mouth Disease：a protocol for systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.1.0032.

Full text
Abstract:
Review question / Objective: The type of study was clinical randomized controlled trial (RCT). The object of study is the patients with HFMD. There is no limit to gender and race. In the case of clear diagnosis standard, curative effect judgment standard and consistent baseline treatment, the experimental group was treated with pure oral liquid of traditional Chinese medicine(A: Fuganlin oral liquid, B: huangzhihua oral liquid, C: Lanqin oral liquid, D: antiviral oral liquid, E: Huangqin oral liquid, F: Pudilan oral liquid, G: Shuanghuanglian oral liquid.)and the control group was treated with
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Ribavirine' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography